361 related articles for article (PubMed ID: 18594554)
1. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.
De Keyser J; Steen C; Mostert JP; Koch MW
J Cereb Blood Flow Metab; 2008 Oct; 28(10):1645-51. PubMed ID: 18594554
[TBL] [Abstract][Full Text] [Related]
2. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
[TBL] [Abstract][Full Text] [Related]
3. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
[TBL] [Abstract][Full Text] [Related]
4. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
Kutzelnigg A; Lucchinetti CF; Stadelmann C; Brück W; Rauschka H; Bergmann M; Schmidbauer M; Parisi JE; Lassmann H
Brain; 2005 Nov; 128(Pt 11):2705-12. PubMed ID: 16230320
[TBL] [Abstract][Full Text] [Related]
5. The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
Lassmann H
Neuroimaging Clin N Am; 2008 Nov; 18(4):563-76, ix. PubMed ID: 19068402
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.
Vos CM; Geurts JJ; Montagne L; van Haastert ES; Bö L; van der Valk P; Barkhof F; de Vries HE
Neurobiol Dis; 2005 Dec; 20(3):953-60. PubMed ID: 16039866
[TBL] [Abstract][Full Text] [Related]
7. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
Vrenken H; Geurts JJ
Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
[TBL] [Abstract][Full Text] [Related]
8. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
9. Vascular aspects of multiple sclerosis.
D'haeseleer M; Cambron M; Vanopdenbosch L; De Keyser J
Lancet Neurol; 2011 Jul; 10(7):657-66. PubMed ID: 21683931
[TBL] [Abstract][Full Text] [Related]
10. Investigation of quantitative magnetisation transfer parameters of lesions and normal appearing white matter in multiple sclerosis.
Cercignani M; Basile B; Spanò B; Comanducci G; Fasano F; Caltagirone C; Nocentini U; Bozzali M
NMR Biomed; 2009 Jul; 22(6):646-53. PubMed ID: 19322806
[TBL] [Abstract][Full Text] [Related]
11. Cerebral white matter blood flow and energy metabolism in multiple sclerosis.
Steen C; D'haeseleer M; Hoogduin JM; Fierens Y; Cambron M; Mostert JP; Heersema DJ; Koch MW; De Keyser J
Mult Scler; 2013 Sep; 19(10):1282-9. PubMed ID: 23428956
[TBL] [Abstract][Full Text] [Related]
12. Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f.
Rausch M; Tofts P; Lervik P; Walmsley A; Mir A; Schubart A; Seabrook T
Mult Scler; 2009 Jan; 15(1):16-27. PubMed ID: 18971220
[TBL] [Abstract][Full Text] [Related]
13. (1)H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis.
Caramanos Z; DiMaio S; Narayanan S; Lapierre Y; Arnold DL
J Neurol Sci; 2009 Jul; 282(1-2):72-9. PubMed ID: 19232641
[TBL] [Abstract][Full Text] [Related]
14. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
[TBL] [Abstract][Full Text] [Related]
15. Identification of fibers at risk for degeneration by diffusion tractography in patients at high risk for MS after a clinically isolated syndrome.
Simon JH; Zhang S; Laidlaw DH; Miller DE; Brown M; Corboy J; Bennett J
J Magn Reson Imaging; 2006 Nov; 24(5):983-8. PubMed ID: 17024655
[TBL] [Abstract][Full Text] [Related]
16. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
Leitner H
Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
[TBL] [Abstract][Full Text] [Related]
17. Fractal dimension and white matter changes in multiple sclerosis.
Esteban FJ; Sepulcre J; de Mendizábal NV; Goñi J; Navas J; de Miras JR; Bejarano B; Masdeu JC; Villoslada P
Neuroimage; 2007 Jul; 36(3):543-9. PubMed ID: 17499522
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
Minagar A; Toledo EG; Alexander JS; Kelley RE
J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
[TBL] [Abstract][Full Text] [Related]
19. Connecting white matter injury and thalamic atrophy in clinically isolated syndromes.
Henry RG; Shieh M; Amirbekian B; Chung S; Okuda DT; Pelletier D
J Neurol Sci; 2009 Jul; 282(1-2):61-6. PubMed ID: 19394969
[TBL] [Abstract][Full Text] [Related]
20. Regional DTI differences in multiple sclerosis patients.
Roosendaal SD; Geurts JJ; Vrenken H; Hulst HE; Cover KS; Castelijns JA; Pouwels PJ; Barkhof F
Neuroimage; 2009 Feb; 44(4):1397-403. PubMed ID: 19027076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
